BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 22491455)

  • 1. Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.
    Sivachandran N; Wang X; Frappier L
    J Virol; 2012 Jun; 86(11):6146-58. PubMed ID: 22491455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies.
    Sivachandran N; Cao JY; Frappier L
    J Virol; 2010 Nov; 84(21):11113-23. PubMed ID: 20719947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.
    Sides MD; Block GJ; Shan B; Esteves KC; Lin Z; Flemington EK; Lasky JA
    Virology; 2011 Jul; 416(1-2):86-97. PubMed ID: 21605886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.
    Bell P; Lieberman PM; Maul GG
    J Virol; 2000 Dec; 74(24):11800-10. PubMed ID: 11090180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
    Adamson AL; Kenney S
    J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression.
    Nicewonger J; Suck G; Bloch D; Swaminathan S
    J Virol; 2004 Sep; 78(17):9412-22. PubMed ID: 15308735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.
    Mansouri S; Pan Q; Blencowe BJ; Claycomb JM; Frappier L
    J Virol; 2014 Oct; 88(19):11166-77. PubMed ID: 25031339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.
    Malik-Soni N; Frappier L
    J Virol; 2012 Jun; 86(12):6999-7002. PubMed ID: 22496234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
    Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.
    Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Tsurumi T
    J Biol Chem; 2004 Dec; 279(52):54817-25. PubMed ID: 15498777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.
    Nawandar DM; Ohashi M; Djavadian R; Barlow E; Makielski K; Ali A; Lee D; Lambert PF; Johannsen E; Kenney SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD; Lee HL; Peng CW
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.
    Hau PM; Deng W; Jia L; Yang J; Tsurumi T; Chiang AK; Huen MS; Tsao SW
    J Virol; 2015 Jan; 89(1):652-68. PubMed ID: 25355892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus origin of lytic replication mediates association of replicating episomes with promyelocytic leukaemia protein nuclear bodies and replication compartments.
    Amon W; White RE; Farrell PJ
    J Gen Virol; 2006 May; 87(Pt 5):1133-1137. PubMed ID: 16603513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.